MedPath

To compare blood loss after normal delivery with use of oxytocin alone and oxytocin with misoprotol

Phase 2
Conditions
Health Condition 1: O720- Third-stage hemorrhage
Registration Number
CTRI/2023/10/059156
Lead Sponsor
Intramural Jawarharlal Institute of Postgraduate Medical Education and Research
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Pregnant women = 18 years of age

2. Gestational age =37 weeks to 42 weeks

3. Following singleton vaginal delivery

Exclusion Criteria

1. Antepartum haemorrhage

2. Pre-existing bleeding disorders

3. Fever ( >38?C)

4. Acute Gastroenteritis

5. Known hypersensitivity to Oxytocin or Misoprostol

6. Distressed due to labour pains to give informed consent

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath